(Q37995237)

26 August 2017

title

The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. (English)

1 reference

26 August 2017

main subject

hepatocellular carcinoma

1 reference

5

Kiyoshi Hasegawa

1 reference

26 August 2017

6

Yasuhiko Sugawara

1 reference

26 August 2017

3

Yoshinori Inagaki

1 reference

26 August 2017

1

Peipei Song

1 reference

26 August 2017

4

Norihiro Kokudo

1 reference

26 August 2017

Ruoyan G Tobe

2

1 reference

26 August 2017

Wei Tang

series ordinal

7

1 reference

26 August 2017

publication date

20 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

32

1 reference

26 August 2017

issue

7

1 reference

26 August 2017

page(s)

1053-1063

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Optimized management of advanced hepatocellular carcinoma: four long-lasting responses to sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

NCCN clinical practice guidelines in oncology: hepatobiliary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Screening tests for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Saudi Gastroenterology Association guidelines for the diagnosis and management of hepatocellular carcinoma: summary of recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Hepatocellular carcinoma: current management and perspectives for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Strategies for the management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Diagnostic and treatment algorithm of the Japanese society of hepatology: a consensus-based practice guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Predictors of survival after resection of early hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Molecular classification and novel targets in hepatocellular carcinoma: recent advancements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

[Practice guidelines for management of hepatocellular carcinoma 2009].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Review article: the management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

The usefulness of NICE guidance in practice: different perspectives of managers, clinicians, and patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Dissemination of evidence-based clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists, liver surgeons and primary care physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

The process of NCCN guidelines adaptation to the Middle East and North Africa region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Hepatocellular carcinoma--epidemiological trends and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

Hepatocellular Carcinoma (HCC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02792.X

10.1111/J.1478-3231.2012.02792.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference